Abiopharma

Clinical trial NCT07490860 updates: 1. enrollment: 57 → 45 participants 2. allocation: NON_RANDOMIZED → NA

Clinical trial NCT07529860: start date: 2026-04-01 → 2026-07-01.

Clinical trial NCT05879432 updates: 1. completion date: 2026-12-01 → 2027-08-01 2. primary completion date: 2026-08-01 → 2027-03-01

Clinical trial NCT06323928 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-04-30 → 2026-03-16

General Announcement: Net Asset Value per unit

Clinical trial NCT05286112 updates: 1. completion date: 2025-03-21 → 2026-02-28 2. primary completion date: 2025-03-21 → 2026-02-28

EXL and Databricks expand collaboration to help enterprises build trusted data foundations for AI

Clinical trial NCT05576896 updates: 1. status: ACTIVE_NOT_RECRUITING → TERMINATED 2. completion date: 2030-07-01 → 2026-04-20 3. primary completion date: 2026-05-26 → 2025-10-24

Clinical trial NCT05215340 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2028-04-30 → 2032-03-04 3. primary completion date: 2028-02-29 → 2030-03-04 4. enrollment type: ESTIMATED → ACTUAL

Clinical trial NCT06109467 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. primary completion date: 2028-04-01 → 2028-03-01 3. enrollment: 36 → 8 participants 4. enrollment type: ESTIMATED → ACTUAL